Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.

Thumbnail
View/Open
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.pdf (717.7Kb)
Date
2021-11-11
ICR Author
Turnbull, Clare
Author
100,000 Genomes Project Pilot Investigators,
Smedley, D
Smith, KR
Martin, A
Thomas, EA
McDonagh, EM
Cipriani, V
Ellingford, JM
Arno, G
Tucci, A
Vandrovcova, J
Chan, G
Williams, HJ
Ratnaike, T
Wei, W
Stirrups, K
Ibanez, K
Moutsianas, L
Wielscher, M
Need, A
Barnes, MR
Vestito, L
Buchanan, J
Wordsworth, S
Ashford, S
Rehmström, K
Li, E
Fuller, G
Twiss, P
Spasic-Boskovic, O
Halsall, S
Floto, RA
Poole, K
Wagner, A
Mehta, SG
Gurnell, M
Burrows, N
James, R
Penkett, C
Dewhurst, E
Gräf, S
Mapeta, R
Kasanicki, M
Haworth, A
Savage, H
Babcock, M
Reese, MG
Bale, M
Baple, E
Boustred, C
Brittain, H
de Burca, A
Bleda, M
Devereau, A
Halai, D
Haraldsdottir, E
Hyder, Z
Kasperaviciute, D
Patch, C
Polychronopoulos, D
Matchan, A
Sultana, R
Ryten, M
Tavares, ALT
Tregidgo, C
Turnbull, C
Welland, M
Wood, S
Snow, C
Williams, E
Leigh, S
Foulger, RE
Daugherty, LC
Niblock, O
Leong, IUS
Wright, CF
Davies, J
Crichton, C
Welch, J
Woods, K
Abulhoul, L
Aurora, P
Bockenhauer, D
Broomfield, A
Cleary, MA
Lam, T
Dattani, M
Footitt, E
Ganesan, V
Grunewald, S
Compeyrot-Lacassagne, S
Muntoni, F
Pilkington, C
Quinlivan, R
Thapar, N
Wallis, C
Wedderburn, LR
Worth, A
Bueser, T
Compton, C
Deshpande, C
Fassihi, H
Haque, E
Izatt, L
Josifova, D
Mohammed, S
Robert, L
Rose, S
Ruddy, D
Sarkany, R
Say, G
Shaw, AC
Wolejko, A
Habib, B
Burns, G
Hunter, S
Grocock, RJ
Humphray, SJ
Robinson, PN
Haendel, M
Simpson, MA
Banka, S
Clayton-Smith, J
Douzgou, S
Hall, G
Thomas, HB
O'Keefe, RT
Michaelides, M
Moore, AT
Malka, S
Pontikos, N
Browning, AC
Straub, V
Gorman, GS
Horvath, R
Quinton, R
Schaefer, AM
Yu-Wai-Man, P
Turnbull, DM
McFarland, R
Taylor, RW
O'Connor, E
Yip, J
Newland, K
Morris, HR
Polke, J
Wood, NW
Campbell, C
Camps, C
Gibson, K
Koelling, N
Lester, T
Németh, AH
Palles, C
Patel, S
Roy, NBA
Sen, A
Taylor, J
Cacheiro, P
Jacobsen, JO
Seaby, EG
Davison, V
Chitty, L
Douglas, A
Naresh, K
McMullan, D
Ellard, S
Temple, IK
Mumford, AD
Wilson, G
Beales, P
Bitner-Glindzicz, M
Black, G
Bradley, JR
Brennan, P
Burn, J
Chinnery, PF
Elliott, P
Flinter, F
Houlden, H
Irving, M
Newman, W
Rahman, S
Sayer, JA
Taylor, JC
Webster, AR
Wilkie, AOM
Ouwehand, WH
Raymond, FL
Chisholm, J
Hill, S
Bentley, D
Scott, RH
Fowler, T
Rendon, A
Caulfield, M
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
BACKGROUND: The U.K. 100,000 Genomes Project is in the process of investigating the role of genome sequencing in patients with undiagnosed rare diseases after usual care and the alignment of this research with health care implementation in the U.K. National Health Service. Other parts of this project focus on patients with cancer and infection. METHODS: We conducted a pilot study involving 4660 participants from 2183 families, among whom 161 disorders covering a broad spectrum of rare diseases were present. We collected data on clinical features with the use of Human Phenotype Ontology terms, undertook genome sequencing, applied automated variant prioritization on the basis of applied virtual gene panels and phenotypes, and identified novel pathogenic variants through research analysis. RESULTS: Diagnostic yields varied among family structures and were highest in family trios (both parents and a proband) and families with larger pedigrees. Diagnostic yields were much higher for disorders likely to have a monogenic cause (35%) than for disorders likely to have a complex cause (11%). Diagnostic yields for intellectual disability, hearing disorders, and vision disorders ranged from 40 to 55%. We made genetic diagnoses in 25% of the probands. A total of 14% of the diagnoses were made by means of the combination of research and automated approaches, which was critical for cases in which we found etiologic noncoding, structural, and mitochondrial genome variants and coding variants poorly covered by exome sequencing. Cohortwide burden testing across 57,000 genomes enabled the discovery of three new disease genes and 19 new associations. Of the genetic diagnoses that we made, 25% had immediate ramifications for clinical decision making for the patients or their relatives. CONCLUSIONS: Our pilot study of genome sequencing in a national health care system showed an increase in diagnostic yield across a range of rare diseases. (Funded by the National Institute for Health Research and others.).
URI
https://repository.icr.ac.uk/handle/internal/5462
DOI
https://doi.org/10.1056/NEJMoa2035790
Collections
  • Other ICR Research
Subject
Adolescent
Adult
Child
Child, Preschool
Family Characteristics
Female
Genetic Variation
Genome, Human
Humans
Male
Middle Aged
Pilot Projects
Polymerase Chain Reaction
Rare Diseases
Sensitivity and Specificity
State Medicine
United Kingdom
Whole Genome Sequencing
Young Adult
Research team
Translational Genetics
Language
eng
Date accepted
2021-11-11
License start date
2021-11-11
Citation
New England Journal of Medicine, 2021, 385 (20), pp. 1868 - 1880
Publisher
MASSACHUSETTS MEDICAL SOC

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.